Michael C. Miggins

Array ( [id] => 5271023 [patent_doc_number] => 20090074799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'ANTIBODIES TO CLASS II CYTOKINE RECEPTOR-7' [patent_app_type] => utility [patent_app_number] => 12/135677 [patent_app_country] => US [patent_app_date] => 2008-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13132 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074799.pdf [firstpage_image] =>[orig_patent_app_number] => 12135677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6513967 [patent_doc_number] => 20100216706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Ghrelin Protects Substantia Nigra Dopamine Neurons' [patent_app_type] => utility [patent_app_number] => 12/600122 [patent_app_country] => US [patent_app_date] => 2008-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20468 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216706.pdf [firstpage_image] =>[orig_patent_app_number] => 12600122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720093 [patent_doc_number] => 20080242616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'PEPTIDE SPECIFICITY OF ANTI-MYELIN BASIS PROTEIN AND THE ADMINISTRATION OF MYELIN BASIC PROTEIN PEPTIDES TO MULTIPLE SCLEROSIS PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/115496 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 13983 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242616.pdf [firstpage_image] =>[orig_patent_app_number] => 12115496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102633 [patent_doc_number] => 07723302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Method of treating Parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 12/113723 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 4671 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723302.pdf [firstpage_image] =>[orig_patent_app_number] => 12113723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272089 [patent_doc_number] => 20090075865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Novel medicament for ameliorating dyskinesia' [patent_app_type] => utility [patent_app_number] => 12/081991 [patent_app_country] => US [patent_app_date] => 2008-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5807 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075865.pdf [firstpage_image] =>[orig_patent_app_number] => 12081991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740555 [patent_doc_number] => 08106015 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Method for enhancing immune response with peptide' [patent_app_type] => utility [patent_app_number] => 12/596741 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11325 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106015.pdf [firstpage_image] =>[orig_patent_app_number] => 12596741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791652 [patent_doc_number] => 20080292625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHY' [patent_app_type] => utility [patent_app_number] => 12/106206 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28085 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292625.pdf [firstpage_image] =>[orig_patent_app_number] => 12106206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507611 [patent_doc_number] => 07915220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Peptidomimetic agents from dextrorotatory amino acids as well as pharmaceutical agents that contain the latter for treatment of neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 11/950539 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3475 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915220.pdf [firstpage_image] =>[orig_patent_app_number] => 11950539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663631 [patent_doc_number] => 20080254538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Treatment of Neurological Deficits in the Striatum or Substanta Nigra Pars Compacta' [patent_app_type] => utility [patent_app_number] => 12/098690 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5068 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254538.pdf [firstpage_image] =>[orig_patent_app_number] => 12098690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4752048 [patent_doc_number] => 20080160121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'INTRACRANIAL BOTULINUM TOXIN THERAPY FOR FOCAL EPILEPSY' [patent_app_type] => utility [patent_app_number] => 12/036760 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27037 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160121.pdf [firstpage_image] =>[orig_patent_app_number] => 12036760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433710 [patent_doc_number] => 20100278814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Prevention and treatment of synucleinopathic and amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 12/037081 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 41246 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278814.pdf [firstpage_image] =>[orig_patent_app_number] => 12037081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8081033 [patent_doc_number] => 08147833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Prevention and treatment of synucleinopathic and amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 12/528439 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41598 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/147/08147833.pdf [firstpage_image] =>[orig_patent_app_number] => 12528439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975854 [patent_doc_number] => 20110070225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Beta antibody parenteral formulation' [patent_app_type] => utility [patent_app_number] => 12/448190 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10592 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070225.pdf [firstpage_image] =>[orig_patent_app_number] => 12448190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785024 [patent_doc_number] => 20080138353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Alpha b-chrystallin as a therapy for inflammation' [patent_app_type] => utility [patent_app_number] => 12/001553 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17062 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138353.pdf [firstpage_image] =>[orig_patent_app_number] => 12001553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251857 [patent_doc_number] => 20100028333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'RECEPTOR FOR AMYLOID BETA AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/519249 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9982 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028333.pdf [firstpage_image] =>[orig_patent_app_number] => 12519249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4475793 [patent_doc_number] => 07906120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)' [patent_app_type] => utility [patent_app_number] => 11/943770 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17373 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906120.pdf [firstpage_image] =>[orig_patent_app_number] => 11943770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718643 [patent_doc_number] => 20080241165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fiber formation and modulating cross-beta structure-mediated toxicity' [patent_app_type] => utility [patent_app_number] => 11/982161 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 26705 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241165.pdf [firstpage_image] =>[orig_patent_app_number] => 11982161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903514 [patent_doc_number] => 20080112927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Cells and methods utilizing same for modifying the electrophysiological function of excitable tissues' [patent_app_type] => utility [patent_app_number] => 11/976166 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 31125 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112927.pdf [firstpage_image] =>[orig_patent_app_number] => 11976166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6626320 [patent_doc_number] => 20100172879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'AMYLOID BETA PEPTIDES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/444647 [patent_app_country] => US [patent_app_date] => 2007-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9259 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172879.pdf [firstpage_image] =>[orig_patent_app_number] => 12444647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795647 [patent_doc_number] => 08124353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Methods of treating and monitoring disease with antibodies' [patent_app_type] => utility [patent_app_number] => 12/311505 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 47822 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124353.pdf [firstpage_image] =>[orig_patent_app_number] => 12311505 [rel_patent_id] =>[rel_patent_doc_number] =>)